Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice

被引:27
作者
Berrocoso, E [1 ]
Rojas-Corrales, MO [1 ]
Micó, JA [1 ]
机构
[1] Univ Cadiz, Fac Med, Dept Neurosci Pharmacol & Psychiat, Pharmacol & Neurosci Res Grp, Cadiz 11003, Spain
关键词
venlafaxine; antidepressants; opioid receptors; naloxone; forced swimming test; mice;
D O I
10.1016/j.neulet.2004.03.041
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The opioid system has been implicated in mood disorders as well as in the mechanism of action of antidepressants. Since the opioid component,in venlafaxine (VLX) is still a matter of discussion, we investigated the role of opioid receptors in the antidepressant-like effect of VLX in the forced swimming test in mice. The non-selective opiate antagonist naloxone at high dose (2 mg/kg, s.c.) antagonized the effect of VLX. In contrast, beta-funaltrexamine (40 mg/kg, s.c.), which preferentially blocks mu(1)/mu(2) opioid receptors, naloxonazine (35 mg/kg, s.c.), a selective mu(1) opioid antagonist, naltrindole (10 mg/kg, s.c.), a selective delta opioid antagonist, and Nor-binaltorphimine (10 mg/kg, s.c.), which selectively blocks kappa-opioid receptors, were all ineffective. Thus, although apparently mediated by the opioid system, the behavioural effect of VLX does not involve specific opioid receptors. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 20 条
[1]   ANTINOCICEPTIVE EFFECTS OF ACUTE AND CHRONIC INJECTIONS OF TRICYCLIC ANTIDEPRESSANT DRUGS IN A NEW MODEL OF MONONEUROPATHY IN RATS [J].
ARDID, D ;
GUILBAUD, G .
PAIN, 1992, 49 (02) :279-287
[2]  
CORBETT A, 1999, OPIOID RECEPTORS
[3]   INFLUENCE OF NALOXONE ON ANTIDEPRESSANT DRUG EFFECTS IN THE FORCED SWIMMING TEST IN MICE [J].
DEVOIZE, JL ;
RIGAL, F ;
ESCHALIER, A ;
TROLESE, JF ;
RENOUX, M .
PSYCHOPHARMACOLOGY, 1984, 84 (01) :71-75
[4]   Mice deficient for δ- and γ-opioid receptors exhibit opposing alterations of emotional responses [J].
Filliol, D ;
Ghozland, S ;
Chluba, J ;
Martin, M ;
Matthes, HWD ;
Simonin, F ;
Befort, K ;
Gavériaux-Ruff, C ;
Dierich, A ;
LeMeur, M ;
Valverde, O ;
Maldonado, R ;
Kieffer, BL .
NATURE GENETICS, 2000, 25 (02) :195-200
[5]   The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system [J].
Marchand, F ;
Alloui, A ;
Chapuy, E ;
Hernandez, A ;
Pelissier, T ;
Ardid, D ;
Eschalier, A .
NEUROSCIENCE LETTERS, 2003, 342 (1-2) :105-108
[6]   Venlafaxine-tramadol similarities [J].
Markowitz, JS ;
Patrick, KS .
MEDICAL HYPOTHESES, 1998, 51 (02) :167-168
[7]   ANTIDEPRESSANT BIOCHEMICAL PROFILE OF THE NOVEL BICYCLIC COMPOUND WY-45,030, AN ETHYL CYCLOHEXANOL DERIVATIVE [J].
MUTH, EA ;
HASKINS, JT ;
MOYER, JA ;
HUSBANDS, GEM ;
NIELSEN, ST ;
SIGG, EB .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (24) :4493-4497
[8]   Venlafaxine for the treatment of neuropathic pain [J].
Pernia, A ;
Micó, JA ;
Calderón, E ;
Torres, LM .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (06) :408-410
[9]   COMPARISON OF NALOXONAZINE AND BETA-FUNALTREXAMINE ANTAGONISM OF MU-1 AND BETA-2 OPIOID ACTIONS [J].
PICK, CG ;
PAUL, D ;
PASTERNAK, GW .
LIFE SCIENCES, 1991, 48 (21) :2005-2011
[10]   DEPRESSION - NEW ANIMAL-MODEL SENSITIVE TO ANTIDEPRESSANT TREATMENTS [J].
PORSOLT, RD ;
LEPICHON, M ;
JALFRE, M .
NATURE, 1977, 266 (5604) :730-732